Nancy Simonian is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as Board Director for Generate:Biomedicines, Alltrna, Syros Pharmaceuticals, and the Damon Runyon Cancer Research Foundation. Simonian holds a position on the Supervisory Board of Bayer and previously contributed to Seagen and Evelo Biosciences as a Board Director. With a wealth of experience, Simonian was the founding CEO of Syros Pharmaceuticals and held roles such as Chief Medical Officer at Millennium Pharmaceuticals and VP of Clinical Development at Biogen. Simonian's academic background includes a BA from Princeton University and an MD from the University of Pennsylvania School of Medicine.